Excel Industries Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 15 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.3K Cr
Current capacity utilization is 70% to 75%, with effective maximum utilization around 85% to 90% due to operational flexibility and maintenance. Excel Industries targets full-year EBITDA margins of 13% to 15% for FY26, reflecting stable profitability despite Q3 being a lean quarter.
From Excel Industries Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,089
Market Cap
₹1.3K Cr
P/E Ratio
17.9
How does Excel Industries Ltd rank in Chemicals & Petrochemicals?
Compare Excel Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Excel Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹281 Cr, net profit ₹12 Cr.
Full financials →📊 Revenue & Sales Performance
- →Current capacity utilization is 70% to 75%, with effective maximum utilization around 85% to 90% due to operational flexibility and maintenance.
- →Existing assets offer headroom for volume growth without immediate need for major expansion.
- →New CAPEX of approximately Rs 200-300 crores planned over next 3 years, including Rs 35-40 crores for a long-term specialty chemical contract manufacturing project expected to generate Rs 35-40 crores in annual revenue.
- →Incremental revenue expected from newly commissioned biocide capacity (~Rs 15 crores annual revenue) and other contract manufacturing projects (~Rs 10-12 crores), with combined potential incremental revenue around Rs 60 crore at peak.
- →Business growth focused on performance solutions segment and contract manufacturing to de-risk agrochemical dependency.
- →Full year FY26 top line growth influenced by subdued agrochemical demand due to extended monsoon; expectation of normalization and potential revival in Q4 or beyond.
- →No specific peak revenue guidance given, due to dynamic pricing and market conditions.
📈 Profitability & Margins
- →Excel Industries targets full-year EBITDA margins of 13% to 15% for FY26, reflecting stable profitability despite Q3 being a lean quarter.
- →Incremental revenue growth is anticipated from contract manufacturing and specialty chemicals, with new long-term contracts expected to generate combined peak revenues of around ₹60 crores by FY27/FY28.
- →The new R&D center, operational in Q3 FY26, is aimed at strengthening product pipeline and innovation, contributing to medium to long-term growth.
- →Capacity utilization currently at 70-75%, with headroom to increase up to 85-90%, indicating potential for volume growth without immediate large-capacity expansion.
- →Strategic investments in R&D and sustainability are expected to support long-term growth and profitability.
- →Despite near-term demand softness due to agrochemical sector disruptions, normalization is expected by Q4 FY26 or later.
- →Overall, management remains optimistic about long-term earnings growth driven by performance solutions and contract manufacturing diversification.
🏗️ Capital Expenditure Plans
- →Excel Industries plans total CAPEX of Rs 200-300 crores over the next three years, covering both maintenance and growth.
- →Recently signed a long-term 5-year contract manufacturing deal requiring Rs 40 crores investment for a dedicated production line, commissioning expected by June 2026.
- →Commissioned a capacity expansion for a key biocide product in October 2025 with Rs 10.33 crores invested; full-year revenue expected at Rs 15 crores.
- →Ongoing debottlenecking and modernization CAPEX of around Rs 35-40 crores excluding raw materials, staggered over 12-18 months, covering multiple projects.
- →New R&D center becoming operational in Q3 FY26 to support innovation and growth initiatives.
- →Strategic investments focus on expanding specialty chemicals, contract manufacturing, and reducing agrochemical sector dependence.
💰 Fundraising & Capital Structure
- →The transcript does not mention any current or future fundraising plans through debt or equity.
- →There is no discussion on issuing new shares, raising capital, or taking on debt during the call.
- →The company focuses on internal funding for its CAPEX plans (₹200-300 crores over 3 years) from operational cash flows.
- →They have confirmed a trade advance of ₹25 crores from a customer related to a contract manufacturing project, but this is not a fundraising activity.
- →Overall, no explicit indication of raising funds via debt or equity at present or in near future was provided.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Excel Industries Ltd Q2 FY26 results?
Current capacity utilization is 70% to 75%, with effective maximum utilization around 85% to 90% due to operational flexibility and maintenance. Excel Industries targets full-year EBITDA margins of 13% to 15% for FY26, reflecting stable profitability despite Q3 being a lean quarter.
What is Excel Industries Ltd share price analysis?
Excel Industries Ltd currently shows a neutral. The stock trades at a P/E of 17.9 with a market cap of ₹1,274 Cr. Investors should review the full earnings analysis for detailed insights.
Is Excel Industries Ltd planning capital expenditure?
Excel Industries plans total CAPEX of Rs 200-300 crores over the next three years, covering both maintenance and growth.
Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.